Strata Oncology

Strata Oncology is a precision oncology company based in Ann Arbor, United States. Its mission is to accelerate the impact of precision medicine for patients with cancer. The company develops advanced algorithmic biomarkers for antibody-drug conjugates (ADCs) and immunotherapy, including Antibody-drug Conjugate Treatment Response Scores and an Immunotherapy Response Score. Dan Rhodes, PhD serves as Co-Founder & CEO, and Scott Tomlins, MD, PhD as Co-founder & Chief Medical Officer.

Strata Oncology is a company in Ann Arbor, United States. It describes itself as a next-generation precision oncology company enabling smarter cancer treatment so that every patient gets their best possible therapy. Its mission is to accelerate the impact of precision medicine for patients with cancer. The company develops advanced algorithmic biomarkers for antibody-drug conjugates and immunotherapy.

Precision oncology; advanced algorithmic biomarkers for antibody-drug conjugates and immunotherapy

• Antibody-drug Conjugate Treatment Response Scores

  Predictive biomarkers for benefit from a variety of approved and investigational antibody-drug conjugates (ADCs); based on a proprietary calculation method of three components including ADC target expression.

• Immunotherapy Response Score

  A pan-solid tumor predictive diagnostic tool for anti-PD-1/PD-L1 monotherapy benefit. This biomarker algorithm combines tumor mutation burden (TMB) with quantitative expression of PD-L1, PD-1, ADAM12 and TOP2A.

1. 1Precision Oncology | Strata Oncologystrataoncology.com
2. 2About Us | Strata Oncologystrataoncology.com
3. 3Strata Oncology (United States)wikidata.org
4. 4Ann Arbor’s Strata Oncology secures $90 million in recent funding roundclickondetroit.com
5. 5Strata Oncology Launches Strata Assistant Epic app to Integrate Precision Oncology into Clinical Practiceprnewswire.com